⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 15 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 52 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 2 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine EU December 8, 2025

Insulin lispro Sanofi

📷 Wikipedia: Insulin lispro · Source
Insulin lispro Sanofi
📷 Wikipedia: Insulin lispro · Source
INN
insulin lispro
Forms
Solution for injection in a cartridge;Solution for injection in pre-filled pen
Strengths
100 units/ml solution for injection in cartridges;100 units/ml solution for injection in pre-filled pen
Alternatives
Yes
🗄
Archived (older alert)
This alert was reported 231 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
17 days in total
May 20, 2026 June 6, 2026

What is this? Insulin lispro is a fast-acting medicine used by people with diabetes to control blood sugar. It comes in cartridges or pre-filled pens.

What's happening? There is a shortage of insulin lispro from Sanofi in the EU. Supplies may be limited in some places.

Does this affect me? If you use insulin lispro Sanofi, you might have trouble finding it. Check with your pharmacy.

What should I do? Talk to your doctor or pharmacist about other insulin options that may work for you.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Brand(s) / product name(s)
Agency-published detail

INN: insulin lispro · Forms: Solution for injection in a cartridge;Solution for injection in pre-filled pen · Strengths: 100 units/ml solution for injection in cartridges;100 units/ml solution for injection in pre-filled pen · Alternatives: Yes

First published
December 8, 2025
Last refreshed by us
1 month ago
Severity (as classified)
High
Official source
http://www.ema.europa.eu/en/medicines/human/shortages/insulin-lispro-sanofi

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
Insulin lispro Sanofi. INN: insulin lispro · Forms: Solution for injection in a cartridge;Solution for injection in pre-filled pen · Strengths: 100 units/ml solution for injection in cartridges;100 units/ml solution for injection in pre-filled pen · Alternatives: Yes
When was this alert issued?
This alert was issued on December 8, 2025 by EMA (European Medicines Agency).
Which countries are affected?
The alert applies to the entire EU.
How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on www.ema.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.